{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:51:51Z","timestamp":1792713111910,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>This narrative review aims to assess the pathophysiology, diagnosis, and treatment of resistant hypertension (RH) in end-stage kidney disease (ESKD) patients on dialysis, with a specific focus on the effect of renal denervation (RDN) on short-term and long-term blood pressure (BP) control. Additionally, we share our experience with the use of RDN in an amyloidotic patient undergoing hemodialysis with RH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>High BP, an important modifiable cardiovascular risk factor, is often observed in patients in ESKD, despite the administration of multiple antihypertensive medications. However, in clinical practice, it remains challenging to identify RH patients on dialysis treatment because of the absence of specific definition for RH in this context. Moreover, the use of invasive approaches, such as RDN, to treat RH is limited by the exclusion of patients with reduced renal function (eGFR\u2009&lt;\u200945\u00a0mL\/min\/1.73 m3) in the clinical trials. Nevertheless, recent studies have reported encouraging results regarding the effectiveness of RDN in stage 3 and 4 chronic kidney disease (CKD) and ESKD patients on dialysis, with reductions in BP of nearly up to 10\u00a0mmhg.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Although multiple underlying pathophysiological mechanisms contribute to RH, the overactivation of the sympathetic nervous system in ESKD patients on dialysis plays a crucial role. The diagnosis of RH requires both confirmation of adherence to antihypertensive therapy and the presence of uncontrolled BP values by ambulatory BP monitoring or home BP monitoring. Treatment involves a combination of nonpharmacological approaches (such as dry weight reduction, sodium restriction, dialysate sodium concentration reduction, and exercise) and pharmacological treatments. A promising approach for managing of RH is based on catheter-based RDN, through radiofrequency, ultrasound, or alcohol infusion, directly targeting on sympathetic overactivity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11906-023-01264-2","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:01:48Z","timestamp":1693998108000},"page":"353-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review"],"prefix":"10.1007","volume":"25","author":[{"given":"Alberto","family":"Mazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Dell\u2019Avvocata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioia","family":"Torin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bulighin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3947-1814","authenticated-orcid":false,"given":"Yuri","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"issue":"1","key":"1264_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.ajkd.2020.04.017","volume":"77","author":"KS Fay","year":"2021","unstructured":"Fay KS, Cohen DL. Resistant hypertension in people with CKD: a review. Am J Kidney Dis. 2021;77(1):110\u201321.","journal-title":"Am J Kidney Dis"},{"issue":"11 Pt 1","key":"1264_CR2","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0895-7061(98)00154-X","volume":"11","author":"J Zazgornik","year":"1998","unstructured":"Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Br\u00fccke P, et al. Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Am J Hypertens. 1998;11(11 Pt 1):1364\u201370.","journal-title":"Am J Hypertens"},{"issue":"7","key":"1264_CR3","volume":"12","author":"M Aldiabat","year":"2020","unstructured":"Aldiabat M, Alabdallah K, Kofahi A, Aziz S. Bilateral nephrectomy, the forgotten measure in the treatment of refractory hypertension in patients with end-stage renal disease: a case report and literature review. Cureus. 2020;12(7): e9031.","journal-title":"Cureus"},{"issue":"2020","key":"1264_CR4","first-page":"2314128","volume":"8","author":"M Provenzano","year":"2020","unstructured":"Provenzano M, Andreucci M, De Nicola L, Garofalo C, Battaglia Y, Borrelli S, et al. The role of prognostic and predictive biomarkers for assessing cardiovascular risk in chronic kidney disease patients. Biomed Res Int. 2020;8(2020):2314128.","journal-title":"Biomed Res Int"},{"issue":"9671","key":"1264_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275\u201381.","journal-title":"Lancet"},{"issue":"6","key":"1264_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324.","journal-title":"Hypertension"},{"issue":"33","key":"1264_CR7","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"5","key":"1264_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cjca.2020.02.083","volume":"36","author":"S Hiremath","year":"2020","unstructured":"Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, et al. Hypertension Canada\u2019s 2020 evidence review and guidelines for the management of resistant hypertension. Can J Cardiol. 2020;36(5):625\u201334.","journal-title":"Can J Cardiol"},{"key":"1264_CR9","unstructured":"Mancia Chairperson G, Kreutz Co-Chair R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023."},{"key":"1264_CR10","doi-asserted-by":"crossref","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403\u201319.","DOI":"10.1161\/HYPERTENSIONAHA.108.189141"},{"issue":"11","key":"1264_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/jch.14042","volume":"22","author":"RM Carey","year":"2020","unstructured":"Carey RM. 2018 American Heart Association redefinition of resistant hypertension: major adverse cardiovascular and renal events. J Clin Hypertens (Greenwich). 2020;22(11):2103\u20134.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1264_CR12","doi-asserted-by":"crossref","unstructured":"Symonides B, Lewandowski J, Ma\u0142yszko J. Resistant hypertension in dialysis. Nephrol Dial Transplant. 2023;gfad047.","DOI":"10.1093\/ndt\/gfad047"},{"issue":"6","key":"1264_CR13","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1046\/j.1523-1755.2000.00107.x","volume":"57","author":"J Amar","year":"2000","unstructured":"Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57(6):2485\u201391.","journal-title":"Kidney Int"},{"issue":"3","key":"1264_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2215\/CJN.01891105","volume":"1","author":"R Agarwal","year":"2006","unstructured":"Agarwal R, Peixoto AJ, Santos SFF, Zoccali C. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1(3):389\u201398.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1264_CR15","doi-asserted-by":"crossref","unstructured":"Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, et al. Hypertension in chronic kidney disease part 1: out-of-office blood pressure monitoring: methods, thresholds, and patterns. hypertension. 2016;67(6):1093\u2013101.","DOI":"10.1161\/HYPERTENSIONAHA.115.06895"},{"issue":"9","key":"1264_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/ndt\/gfv241","volume":"30","author":"C Zoccali","year":"2015","unstructured":"Zoccali C, Tripepi R, Torino C, Tripepi G, Mallamaci F. Moderator\u2019s view: ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. Nephrol Dial Transplant. 2015;30(9):1443\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"1264_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/5584_2016_88","volume":"956","author":"M Hommos","year":"2017","unstructured":"Hommos M, Schinstock C. Hypertension in the hemodialysis patient. Adv Exp Med Biol. 2017;956:327\u201340.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1264_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2002.30542","volume":"39","author":"MP H\u00f6rl","year":"2002","unstructured":"H\u00f6rl MP, H\u00f6rl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39(2):227\u201344.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1264_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0272-6386(96)90309-1","volume":"28","author":"S Fishbane","year":"1996","unstructured":"Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis. 1996;28(2):257\u201361.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1264_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ndt\/gfw433","volume":"32","author":"PA Sarafidis","year":"2017","unstructured":"Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant. 2017;32(4):620\u201340.","journal-title":"Nephrol Dial Transplant"},{"key":"1264_CR21","doi-asserted-by":"crossref","unstructured":"Battaglia Y, Fiorini F, Gisonni P, Imbriaco M, Lentini P, Zeiler M, et al. Ultrasonographic assessment of atherosclerotic renal artery stenosis in elderly patients with chronic kidney disease: an Italian cohort study. Diagnostics (Basel). 2022;12(6):1454.","DOI":"10.3390\/diagnostics12061454"},{"issue":"3","key":"1264_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.108.125674","volume":"53","author":"R Agarwal","year":"2009","unstructured":"Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension. 2009;53(3):500\u20137.","journal-title":"Hypertension"},{"issue":"2","key":"1264_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0272-6386(99)70346-X","volume":"34","author":"M Ozkahya","year":"1999","unstructured":"Ozkahya M, T\u00f6z H, Unsal A, Ozerkan F, Asci G, G\u00fcrg\u00fcn C, et al. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis. 1999;34(2):218\u201321.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1264_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/ajkd.2001.22085","volume":"37","author":"AI G\u00fcnal","year":"2001","unstructured":"G\u00fcnal AI, Duman S, Ozkahya M, T\u00f6z H, As\u00e7i G, Ak\u00e7i\u00e7ek F, Bas\u00e7i A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37(3):588\u201393.","journal-title":"Am J Kidney Dis"},{"issue":"27","key":"1264_CR25","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse Jr","year":"1992","unstructured":"Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327(27):1912\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"1264_CR26","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","volume":"57","author":"G Grassi","year":"2011","unstructured":"Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell\u2019Oro R, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension. 2011;57(4):846\u201351.","journal-title":"Hypertension"},{"issue":"5","key":"1264_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2008040402","volume":"20","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20(5):933\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1264_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/cphy.c100043","volume":"1","author":"EJ Johns","year":"2011","unstructured":"Johns EJ, Kopp UC, DiBona GF. Neural control of renal function. Compr Physiol. 2011;1(2):731\u201367.","journal-title":"Compr Physiol"},{"issue":"8","key":"1264_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-015-0571-z","volume":"17","author":"IM Salman","year":"2015","unstructured":"Salman IM. Cardiovascular autonomic dysfunction in chronic kidney disease: a comprehensive review. Curr Hypertens Rep. 2015;17(8):59.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"1264_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-021-01129-6","volume":"23","author":"F Quarti-Trevano","year":"2021","unstructured":"Quarti-Trevano F, Seravalle G, Dell\u2019Oro R, Mancia G, Grassi G. Autonomic cardiovascular alterations in chronic kidney disease: effects of dialysis, kidney transplantation, and renal denervation. Curr Hypertens Rep. 2021;23(2):10.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"1264_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ki.1991.236","volume":"40","author":"A Agarwal","year":"1991","unstructured":"Agarwal A, Anand IS, Sakhuja V, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 1991;40(3):489\u201395.","journal-title":"Kidney Int"},{"issue":"1","key":"1264_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1523-1755.2005.00411.x","volume":"68","author":"CT Chan","year":"2005","unstructured":"Chan CT, Jain V, Picton P, Pierratos A, Floras JS. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int. 2005;68(1):338\u201344.","journal-title":"Kidney Int"},{"issue":"4","key":"1264_CR33","first-page":"175","volume":"25","author":"F Mallamaci","year":"1986","unstructured":"Mallamaci F, Zoccali C, Ciccarelli M, Briggs JD. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol. 1986;25(4):175\u201380.","journal-title":"Clin Nephrol"},{"issue":"5","key":"1264_CR34","doi-asserted-by":"publisher","first-page":"H1760","DOI":"10.1152\/ajpheart.00012.2009","volume":"297","author":"CF Notarius","year":"2009","unstructured":"Notarius CF, Morris BL, Floras JS. Dissociation between reflex sympathetic and forearm vascular responses to lower body negative pressure in heart failure patients with coronary artery disease. Am J Physiol Heart Circ Physiol. 2009;297(5):H1760\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"1264_CR35","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrneph.2016.129","volume":"12","author":"PI Georgianos","year":"2016","unstructured":"Georgianos PI, Agarwal R. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol. 2016;12(10):636\u201347.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1264_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40620-019-00696-x","volume":"33","author":"C Torino","year":"2020","unstructured":"Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, et al. Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study. J Nephrol. 2020;33(3):583\u201390.","journal-title":"J Nephrol"},{"key":"1264_CR37","unstructured":"Puntoni A, Giannese D, Varricchio E, D\u2019Alessandro C, Egidi MF, Cupisti A. Different methods to manage dry weight in hemodialysis patients. G Ital Nefrol. 2020;37(1):2020-vol1. Italian."},{"issue":"6","key":"1264_CR38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.kint.2021.07.024","volume":"100","author":"C Zoccali","year":"2021","unstructured":"Zoccali C, Torino C, Mallamaci F, Sarafidis P, Papagianni A, Ekart R, et al. A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk. Kidney Int. 2021;100(6):1325\u201333.","journal-title":"Kidney Int"},{"issue":"8","key":"1264_CR39","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.21037\/qims.2020.03.05","volume":"10","author":"A Sabatino","year":"2020","unstructured":"Sabatino A, D\u2019Alessandro C, Regolisti G, di Mario F, Guglielmi G, Bazzocchi A, et al. Muscle mass assessment in renal disease: the role of imaging techniques. Quant Imaging Med Surg. 2020;10(8):1672\u201386.","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"1264_CR40","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/nu12051388","volume":"12","author":"Y Battaglia","year":"2020","unstructured":"Battaglia Y, Ullo I, Massarenti S, Esposito P, Prencipe M, Ciancio G, et al. Ultrasonography of quadriceps femoris muscle and subcutaneous fat tissue and body composition by BIVA in chronic dialysis patients. Nutrients. 2020;12(5):1388.","journal-title":"Nutrients"},{"key":"1264_CR41","doi-asserted-by":"crossref","unstructured":"Bansal N, Artinian NT, Bakris G, Chang T, Cohen J, Flythe J, et al. Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current evidence and future opportunities: a scientific statement from the American Heart Association. Hypertension. 2023;80(6):e112-e122.","DOI":"10.1161\/HYP.0000000000000230"},{"issue":"13","key":"1264_CR42","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.3390\/ijms21134744","volume":"21","author":"S Borrelli","year":"2020","unstructured":"Borrelli S, Provenzano M, Gagliardi I, Michael A, Liberti ME, De Nicola L, et al. Sodium intake and chronic kidney disease. Int J Mol Sci. 2020;21(13):4744.","journal-title":"Int J Mol Sci"},{"key":"1264_CR43","doi-asserted-by":"crossref","unstructured":"Battaglia Y, Amicone M, Mantovani A, Combe C, Mitra S, Basile C. Home-based exercise in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trials. Nephrol Dial Transplant. 2023;gfad102.","DOI":"10.1093\/ndt\/gfad102"},{"issue":"2\u20133","key":"1264_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000355796","volume":"39","author":"F Aucella","year":"2014","unstructured":"Aucella F, Gesuete A, Battaglia Y. A \u201cnephrological\u201d approach to physical activity. Kidney Blood Press Res. 2014;39(2\u20133):189\u201396.","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"1264_CR45","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4103\/1319-2442.352418","volume":"32","author":"LM AlSahli","year":"2021","unstructured":"AlSahli LM, AlHinti S, AlOmar R, AlSulaimani A, Abdallah M, Al-Sayyari A. Associations between body mass index in hemodialysis patients and comorbidity, dialysis adequacy, blood pressure control, vascular access type, and hospital admission rate. Saudi J Kidney Dis Transpl. 2021;32(6):1577\u201385.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1264_CR46","unstructured":"Battaglia Y, Lamberti N, Piva G, Manfredini F, Storari A. Physical exercise in chronic kidney disease: an empty narrative or an effective intervention? G Ital Nefrol. 2021;38(6):2021-vol6. Italian."},{"issue":"8","key":"1264_CR47","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/ndt\/gfy045","volume":"33","author":"HML Young","year":"2018","unstructured":"Young HML, March DS, Graham-Brown MPM, Jones AW, Curtis F, Grantham CS, et al. Effects of intradialytic cycling exercise on exercise capacity, quality of life, physical function and cardiovascular measures in adult haemodialysis patients: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018;33(8):1436\u201345.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1264_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/mps3040083","volume":"3","author":"F Manfredini","year":"2020","unstructured":"Manfredini F, Lamberti N, Battaglia Y, Straudi S, Belvederi Murri M, Donadi M, et al. A personalized patient-centered intervention to empower through physical activity the patient in the dialysis center: study protocol for a pragmatic nonrandomized clinical trial. Methods Protoc. 2020;3(4):83.","journal-title":"Methods Protoc"},{"key":"1264_CR49","doi-asserted-by":"crossref","unstructured":"Bolignano D, Torino C, Manfredini F, Aucella F, Barill\u00e0 A, Battaglia Y, Bertoli S, Bonanno G, Castellino P, Ciurlino D, Cupisti A, D\u2019Arrigo G, De Paola L, Fabrizi F, Fatuzzo P, Fuiano G, Lombardi L, Lucisano G, Messa P, Rapan\u00e0 R, Rapisarda F, Rastelli S, Rocca-Rey L, Summaria C, Zuccal\u00e0 A, Abd ElHafeez S, Tripepi G, Catizone L, Mallamaci F, Zoccali C; EXCITE Working Group. Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. Kidney Blood Press Res. 2014;39(2-3):197\u2013204.","DOI":"10.1159\/000355797"},{"key":"1264_CR50","doi-asserted-by":"crossref","unstructured":"Denker MG, Cohen DL. Antihypertensive medications in end-stage renal disease. Semin Dial. 2015;28(4):330\u20136.","DOI":"10.1111\/sdi.12369"},{"issue":"9","key":"1264_CR51","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","volume":"41","author":"G Cice","year":"2003","unstructured":"Cice G, Ferrara L, D\u2019Andrea A, D\u2019Isa S, Di Benedetto A, Cittadini A, et al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol. 2003;41(9):1438\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1264_CR52","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ndt\/gft515","volume":"29","author":"R Agarwal","year":"2014","unstructured":"Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant. 2014;29(3):672\u201381.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1264_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188975","volume":"12","author":"YC Lin","year":"2017","unstructured":"Lin YC, Lin JW, Wu MS, Chen KC, Peng CC, Kang YN. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: a systematic review and meta-analysis. PLoS ONE. 2017;12(12): e0188975.","journal-title":"PLoS ONE"},{"key":"1264_CR54","doi-asserted-by":"crossref","unstructured":"Tai DJ, Lim TW, James MT, Manns BJ, Tonelli M, Hemmelgarn BR, et al. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clin J Am Soc Nephrol. 2010;5(4):623\u201330.","DOI":"10.2215\/CJN.07831109"},{"issue":"7","key":"1264_CR55","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","volume":"70","author":"F Zannad","year":"2006","unstructured":"Zannad F, Kessler M, Lehert P, Gr\u00fcnfeld JP, Thuilliez C, Leizorovicz A, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 2006;70(7):1318\u201324. https:\/\/doi.org\/10.1038\/sj.ki.5001657. Epub 2006 Jul 19.","journal-title":"Kidney Int"},{"key":"1264_CR56","doi-asserted-by":"crossref","unstructured":"Iseki K, Arima H, Kohagura K, Komiya I, Ueda S, Tokuyama K, et al. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial. Nephrol Dial Transplant. 2013;28(6):1579\u201389.","DOI":"10.1093\/ndt\/gfs590"},{"key":"1264_CR57","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1-S87.","DOI":"10.1016\/j.kint.2020.11.003"},{"issue":"5","key":"1264_CR58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000168471","volume":"12","author":"RW Van Olden","year":"1992","unstructured":"Van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol. 1992;12(5):351\u20136.","journal-title":"Am J Nephrol"},{"key":"1264_CR59","doi-asserted-by":"crossref","unstructured":"Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, et al. Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. Kidney Int. 2019;95(4):973\u2013982.","DOI":"10.1016\/j.kint.2018.08.034"},{"issue":"11","key":"1264_CR60","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","volume":"23","author":"M Tepel","year":"2008","unstructured":"Tepel M, Hopfenmueller W, Scholze A, Maier A, Zidek W. Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients. Nephrol Dial Transplant. 2008;23(11):3605\u201312.","journal-title":"Nephrol Dial Transplant"},{"key":"1264_CR61","doi-asserted-by":"crossref","unstructured":"Mugendi GA, Mutua FM, Natale P, Esterhuizen TM, Strippoli GF. Calcium channel blockers for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. 2020;10(10):CD011064.","DOI":"10.1002\/14651858.CD011064.pub2"},{"issue":"3","key":"1264_CR62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/j.ajkd.2010.02.348","volume":"56","author":"P Muntner","year":"2010","unstructured":"Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2010;56(3):447\u201357.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1264_CR63","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000321688","volume":"32","author":"KE Schmitt","year":"2010","unstructured":"Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32(6):541\u20138.","journal-title":"Am J Nephrol"},{"issue":"3","key":"1264_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1053\/j.ajkd.2010.04.021","volume":"56","author":"DE Rifkin","year":"2010","unstructured":"Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis. 2010;56(3):439\u201346.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1264_CR65","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1590\/S0100-879X2011007500013","volume":"44","author":"EJ Magacho","year":"2011","unstructured":"Magacho EJ, Ribeiro LC, Chaoubah A, Bastos MG. Adherence to drug therapy in kidney disease. Braz J Med Biol Res. 2011;44(3):258\u201362.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"1264_CR66","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/ndt\/gfu015","volume":"30","author":"M Burnier","year":"2015","unstructured":"Burnier M, Pruijm M, Wuerzner G, Santschi V. Drug adherence in chronic kidney diseases and dialysis. Nephrol Dial Transplant. 2015;30(1):39\u201344.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1264_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021161","volume":"8","author":"DJ Pereira Gray","year":"2018","unstructured":"Pereira Gray DJ, Sidaway-Lee K, White E, Thorne A, Evans PH. Continuity of care with doctors-a matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018;8(6): e021161.","journal-title":"BMJ Open"},{"key":"1264_CR68","doi-asserted-by":"crossref","unstructured":"\u2022 Barbato E, Azizi M, Schmieder RE, Lauder L, B\u00f6hm M, Brouwers S, et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2023;44(15):1313\u20131330. The Group Experts provide evidence-based suggestions on how to implement renal denervation for treating resistant hypertension in clinical practice, emphasizing the importance of shared decision-making process that includes the perspective of patients.","DOI":"10.1093\/eurheartj\/ehad054"},{"issue":"2","key":"1264_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15420\/icr.2019.03.R1","volume":"14","author":"P Lurz","year":"2019","unstructured":"Lurz P, Fengler K. Lessons learned from RADIOSOUND-HTN: different technologies and techniques for catheter-based renal denervation and their effect on blood pressure. Interv Cardiol. 2019;14(2):102\u20136.","journal-title":"Interv Cardiol"},{"issue":"6","key":"1264_CR70","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","volume":"33","author":"C Ott","year":"2015","unstructured":"Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, et al. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension. J Hypertens. 2015;33(6):1261\u20136.","journal-title":"J Hypertens"},{"key":"1264_CR71","unstructured":"Available online at: https:\/\/clinicaltrials.gov. Identifier Number: NCT02910414. (accessed September 1, 2023)"},{"key":"1264_CR72","unstructured":"Available online at: https:\/\/clinicaltrials.gov. Identifier Number: NCT03503773. (accessed September 1, 2023)"},{"issue":"42","key":"1264_CR73","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","volume":"40","author":"F Mahfoud","year":"2019","unstructured":"Mahfoud F, B\u00f6hm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. Eur Heart J. 2019;40(42):3474\u201382.","journal-title":"Eur Heart J"},{"key":"1264_CR74","doi-asserted-by":"crossref","unstructured":"Hering D, Marusic P, Duvak J, Sata Y, Head GA, Burrows S, et al. Effect of renal denervation on kidney function in patients with chronic kidney disease. Int J Cardiol 2017;22(1):93\u201397.","DOI":"10.1016\/j.ijcard.2017.01.047"},{"issue":"9","key":"1264_CR75","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/HJH.0000000000000210","volume":"32","author":"E De Beus","year":"2014","unstructured":"De Beus E, de Jager R, Joles JA, Grassi G, Blankestijn PJ. Sympathetic activation secondary to chronic kidney disease: ther- apeutic target for renal denervation? J Hypertens. 2014;32(9):1751\u201361.","journal-title":"J Hypertens"},{"key":"1264_CR76","doi-asserted-by":"crossref","unstructured":"Hoye NA, Wilson LC, Wilkins GT, Jardine DL, Putt TL, Sama- ranayaka A, et al. Endovascular renal denervation in end-stage kidney disease patients: cardio- vascular protection\u2014a proof-of-concept study. Kidney Int Rep. 2017;2(5):856\u2013865.","DOI":"10.1016\/j.ekir.2017.04.012"},{"key":"1264_CR77","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/S0140-6736(14)60910-7","volume":"383","author":"E O'Brien","year":"2014","unstructured":"O\u2019Brien E. Renal denervation for resistant hypertension: the Symplicity HTN-1 study. Lancet. 2014;383:1884.","journal-title":"Lancet"},{"key":"1264_CR78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jch.12789","volume":"6","author":"AE Burchell","year":"2016","unstructured":"Burchell AE, Chan K, Ratcliffe LE, Hart EC, Saxena M, Collier DJ, et al. Controversies surrounding renal denervation: lessons learned from real-world experience in two United Kingdom centers. J Clin Hypertens (Greenwich). 2016;6:585\u201392.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1264_CR79","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ndt\/gfab154","volume":"37","author":"C Ott","year":"2021","unstructured":"Ott C, Mahfoud F, Mancia G, et al. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years. Nephrol Dial Transplant. 2021;37:304\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"1264_CR80","doi-asserted-by":"crossref","unstructured":"\u2022 Schmieder RE, Mahfoud F, Mancia G, Azizi M, B\u00f6hm M, Dimitriadis K, et al. European Society of Hypertension position paper on renal denervation 2021. J Hypertens. 2021 Sep 1;39(9):1733\u20131741. This paper provides a comprehensive summary of the updated recommendations regarding the efficacy and safety of endovascular device-based renal denervation for hypertension treatment, taking in account the most recent evidence.","DOI":"10.1097\/HJH.0000000000002933"},{"issue":"4","key":"1264_CR81","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/ndt\/gfs044","volume":"27","author":"N Di Daniele","year":"2012","unstructured":"Di Daniele N, De Francesco M, Violo L, Spinelli A, Simonetti G. Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient. Nephrol Dial Transplant. 2012;27(4):1689\u201390.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1264_CR82","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.ijcard.2013.01.218","volume":"168","author":"MP Schlaich","year":"2013","unstructured":"Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, et al. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168(3):2214\u201320.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1264_CR83","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10157-019-01697-7","volume":"23","author":"C Ott","year":"2019","unstructured":"Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE. Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience. Clin Exp Nephrol. 2019;23(6):749\u201355.","journal-title":"Clin Exp Nephrol"},{"issue":"19","key":"1264_CR84","doi-asserted-by":"publisher","first-page":"985","DOI":"10.12659\/AJCR.909820","volume":"21","author":"PM Pietil\u00e4-Effati","year":"2018","unstructured":"Pietil\u00e4-Effati PM, Salmela AK, Koistinen MJ. Intravascular renal denervation in renal dialysis patients with uncontrolled hypertension: a case series of four patients. Am J Case Rep. 2018;21(19):985\u201391.","journal-title":"Am J Case Rep"},{"key":"1264_CR85","doi-asserted-by":"crossref","unstructured":"\u2022 Scalise F, Sole A, Singh G, Sorropago A, Sorropago Balla-beni C, Maccario M, et al. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term hemodialysis. J Hypertens 2020;38(5):936\u2013942. The results of this study suggested renal denervation is effective in reducing both ambulatory and office blood pressure in patients on long-term hemodialysis, with the effects persisting over a 1-year follow-up period.","DOI":"10.1097\/HJH.0000000000002358"},{"key":"1264_CR86","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/02656736.2021.1916100","volume":"38","author":"M Xia","year":"2021","unstructured":"Xia M, Liu T, Chen D, et al. Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis. Int J Hyperthermia. 2021;38:732\u201342.","journal-title":"Int J Hyperthermia"}],"updated-by":[{"DOI":"10.1007\/s11906-023-01270-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000}}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-023-01264-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T09:33:29Z","timestamp":1698140009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-023-01264-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s11906-023-01264-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11906-023-01270-4","asserted-by":"object"}]},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"22 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11906-023-01270-4","URL":"https:\/\/doi.org\/10.1007\/s11906-023-01270-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study has been conducted according to the 1995 Declaration of Helsinki and its revisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}